InvestInfoAI
BlackBarn Capital Partners LP

Q4 2025 · 13F-HR

BlackBarn Capital Partners LPholdings as filed

Filed 2026-02-17 · accession 0002010204-26-000001

$1.52B
Reported value
16
Positions
2025-12-31
Period end
View analyzed profile →PRO

The Brief · BlackBarn Capital Partners LP · Q4 2025

AI · grounded in 13F

BlackBarn Capital Partners LP established a new position in SPY valued at $1.02B. The fund also initiated new stakes in RMD for $96.3M and ROIV for $66.9M. Additional new positions include WRBY at $65.4M, ELAN at $38.5M, and DHC at $31.7M.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
78462F103SPYSPDR S&P 500 ETF TR$1.02B67.3%1,500,000PUTSOLE
761152107RMDRESMED INC$96.3M6.34%400,000PUTSOLE
G76279101ROIVROIVANT SCIENCES LTD$66.9M4.40%3,084,300CommonSOLE
93403J106WRBYWARBY PARKER INC$65.4M4.30%3,000,000PUTSOLE
28414H103ELANELANCO ANIMAL HEALTH INC$38.5M2.53%1,700,000PUTSOLE
25525P107DHCDIVERSIFIED HEALTHCARE TR$31.7M2.08%6,530,140CommonSOLE
74276R102PRVAPRIVIA HEALTH GROUP INC$30.8M2.03%1,300,000CommonSOLE
G63755105NIQNIQ GLOBAL INTELLIGENCE PLC$29.7M1.95%1,800,000CommonSOLE
65339F101NEENEXTERA ENERGY INC$26.9M1.77%335,000CommonSOLE
580907103MHMCGRAW HILL INC$23.1M1.52%1,400,000CommonSOLE
03168L105AMRXAMNEAL PHARMACEUTICALS INC$19.8M1.30%1,570,000CommonSOLE
92686J106VKTXVIKING THERAPEUTICS INC$19.3M1.27%550,000CommonSOLE
687793109OSCROSCAR HEALTH INC$18.7M1.23%1,300,000PUTSOLE
19239V302CCOICOGENT COMMUNICATIONS HLDGS$14.0M0.92%650,000CommonSOLE
03879J100ABUSARBUTUS BIOPHARMA CORP$8.9M0.59%1,850,000CommonSOLE
054540208ACLSAXCELIS TECHNOLOGIES INC$7.8M0.51%96,573CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.